|
CFLAR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.81709999772062E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.00030033939925E-10 |
| Normal-vs-Stage2 |
3.580800E-03 |
| Normal-vs-Stage3 |
2.695600E-03 |
| Normal-vs-Stage4 |
8.476800E-03 |
| Stage1-vs-Stage2 |
8.817200E-01 |
| Stage1-vs-Stage3 |
5.206100E-02 |
| Stage1-vs-Stage4 |
8.946500E-02 |
| Stage2-vs-Stage3 |
2.656800E-01 |
| Stage2-vs-Stage4 |
3.035000E-01 |
| Stage3-vs-Stage4 |
9.985400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.13710005247947E-09 |
| Normal-vs-AfricanAmerican |
1.093830E-01 |
| Normal-vs-Asian |
2.834300E-02 |
| Caucasian-vs-AfricanAmerican |
7.567500E-02 |
| Caucasian-vs-Asian |
4.634100E-02 |
| AfricanAmerican-vs-Asian |
5.896400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.21850000003965E-06 |
| Normal-vs-Female |
1.65650004824158E-09 |
| Male-vs-Female |
1.865700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.080600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.32320000015385E-07 |
| Normal-vs-Age(61-80Yrs) |
2.86390000048264E-07 |
| Normal-vs-Age(81-100Yrs) |
2.143800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.761400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.849800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.237000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.475200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.058400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.426400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.421200E-03 |
| Normal-vs-Grade 2 |
1.05759999646793E-08 |
| Normal-vs-Grade 3 |
1.13779999999508E-06 |
| Normal-vs-Grade 4 |
3.862100E-02 |
| Grade 1-vs-Grade 2 |
2.682000E-01 |
| Grade 1-vs-Grade 3 |
2.149400E-01 |
| Grade 1-vs-Grade 4 |
5.899900E-02 |
| Grade 2-vs-Grade 3 |
5.677000E-01 |
| Grade 2-vs-Grade 4 |
6.712200E-02 |
| Grade 3-vs-Grade 4 |
1.831180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.22124532708767E-15 |
| Normal-vs-ccB subtype |
5.720400E-02 |
| ccA subtype-vs-ccB subtype |
1.153600004411E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.21940000050469E-07 |
| Normal-vs-N1 |
7.626200E-02 |
| N0-vs-N1 |
7.853400E-01 |
|
|
